Cidara Therapeutics Inc
NASDAQ:CDTX

Watchlist Manager
Cidara Therapeutics Inc Logo
Cidara Therapeutics Inc
NASDAQ:CDTX
Watchlist
Price: 221.38 USD Market Closed
Market Cap: 7B USD

Profitability Summary

Cidara Therapeutics Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Cidara Therapeutics Inc

Margins Comparison
Cidara Therapeutics Inc Competitors

Country Company Market Cap Operating
Margin
Net
Margin
US
Cidara Therapeutics Inc
NASDAQ:CDTX
6.5B USD
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
378.3B USD
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
178.1B USD
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
154.2B USD
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.3B USD
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.3B USD
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
84.5B AUD
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
41.9B EUR
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
46.9B USD
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Cidara Therapeutics Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Cidara Therapeutics Inc
NASDAQ:CDTX
6.5B USD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
378.3B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
178.1B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
154.2B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.3B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.3B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
84.5B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
41.9B EUR
Loading...
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
46.9B USD
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Cidara Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate